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ABSTRACT
Baicalin, baicalein and wogonin are bioactive flavonoids of Scutellariae Radix. In order to compare the contents of baicalin, baicalein
and wogonin between traditional decoction and commercial extract, ten crude drugs and ten commercial extracts of Scutellariae Radix
were purchased from the market. High performance liquid chromatographic method was used for simultaneous assay of these flavonoid
constituents. The separation was performed on an Inertsil ODS-2 column with acetonitrile - 0.005% phosphoric acid (36:64, v/v) as mobile
phase at a flow-rate of 1.0 mL/min and detection at 270 nm, and ethyl paraben was used as the internal standard. This method is applicable for the routine quality control of the crude drug and commercial extract of Scutellariae Radix.
The results indicated that the contents of baicalin, baicalein and wogonin in traditional decoctions of each gram of Scutellariae Radix
were 62.7 ± 4.6 mg, 5.5 ± 0.2 mg and 1.7 ± 0.1 mg, whereas those in each gram of commercial extracts were 82.3 ± 8.5 mg, 15.0 ± 2.0 mg
and 5.3 ± 0.5 mg, respectively.
The suggested daily doses of crude drug and commercial extract of Scutellariae Radix are 3.0 – 9.0 g and 0.4 – 9.0 g, respectively.
Based on our results, the contents of baicalin, baicalein and wogonin in the maximum daily doses for traditional decoctions of Scutellariae
Radix were 564.7 ± 41.7 mg, 49.7 ± 1.9 mg and 15.6 ± 1.0 mg, whereas those for commercial extracts were 241.9 ± 41.1 mg, 53.7 ± 16.4
mg and 17.9 ± 4.6 mg, respectively.
Key words: Scutellariae Radix, baicalin, baicalein, wogonin, decoction, commercial extract

INTRODUCTION
Baicalin, baicalein and wogonin whose structures are
shown in Figure 1 are bioactive flavone constituents of
Scutellariae Radix. This crude drug is widely used in clinical
Chinese medicine as a remedy for inflammation, fever and
allergic diseases. In recent studies, baicalin, baicalein, and
wogonin have been reported to show anti-inflammatory(1-4),
anti-allergic(5), antioxidant(6-8) and anticancer activities(9,10).
In addition, baicalin also possessed antiviral activity(11-13)
and baicalein showed a hypotensive effect(14,15).
Traditional Chinese medicines are generally administered as decoctions. In recent decades, herbal extract in granule or powder form has been commercialized for clinical use
and is the only dosage form of Chinese medicine that is covered by the national health insurance plan in Taiwan. It is
important for clinicians to know the contents of these bioactive markers in both traditional decoction and commercial
extract in order to decide a proper dosage regimen. This
study simultaneously determined baicalin, baicalein and
wogonin in both dosage forms of Scutellariae Radix by using
an HPLC method with isocratic elution. The object of this
study was to analyze and compare their contents in traditional decoctions and commercial extracts based on maximum
daily dose.
* Author for correspondence. Tel: 04-22053366 ext. 1905;
Fax: 04-22031028; E-mail:pdlee@mail.cmc.edu.tw

Figure 1. Structures of baicalin, baicalein and wogonin.
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MATERIALS AND METHODS

filtered and combined, then sufficient 70% MeOH was added
to make 100 mL and frozen at -30˚C pending analysis.

I. Materials and Reagents
VI. Assay of Baicalin, Baicalein and Wogonin in Samples
Ten crude drugs of Scutellariae Radix were purchased
from ten herbal stores at northern, central and southern
Taiwan. Ten brands of commercial extracts of Scutellariae
Radix were obtained from herbal stores in Taichung.
Baicalin, baicalein and wogonin standards were obtained
from Wako (Osaka, Japan). Acetonitrile and methanol (LC
grade) were purchased from Mallinckrodt Baker, Inc.
(U.S.A.). Phosphoric acid and other reagents used were of
analytical grade. Milli-Q plus water (Millipore, Bedford,
MA, U.S.A.) was used throughout the study.
II. Instruments and HPLC Conditions
The HPLC apparatus was equipped with one pump (LC6AD, Shimadzu, Japan), an UV spectrophotometric detector
(SPD-6A, Shimadzu Japan) and chromatopac (C-R6A,
Shimadzu, Japan) with an automatic injector (Series 200
Autosampler, Perkin Elmer, U.S.A.). The Inertsil ODS-2 column (5 µm, 4.6 × 250 mm) was equipped with a guard column (4.6 × 50 mm) (GL Science Inc., Japan). The mobile
phase was composed of acetonitrile – 0.005% phosphoric
acid (36:64, v/v). The flow-rate was 1.0 mL/min and detection at 270 nm.
III. Preparations of Standard Solutions
Baicalin, baicalein and wogonin were accurately
weighed and dissolved in methanol to give a series of concentrations in the ranges of 3.1 – 100.0, 2.5 – 80.0 and 2.5 –
80.0 µg/mL, respectively. An equal volume of internal standard solution (ethyl paraben in methanol, 20.0 µg/mL) was
added to each standard to afford a final concentration of 10.0
µg/mL. Calibration graphs were plotted by linear regression
of the peak-area ratios (drug/internal standard) against concentrations of drugs.
IV. Preparations of Traditional Decoctions
Scutellariae Radix was cut into homogeneous pieces
and 2.0 g was weighed for each sample. These samples were
added to 80 mL of H2O, heated on a plate heater and boiled
for about 2 hr until the volume was slightly less than 20 mL.
Each decoction was filtered while hot and hot water was
added to make 20 mL. Marc was added to 40 mL of H2O and
heated to boiling again for 1 hr and was concentrated to
slightly less than 10 mL. The filtered decoction was added
with hot water to make 10 mL. An aliquot of each extract was
frozen at -30˚C pending analysis.
V. Extraction of Commercial Herbal Extracts
Ten brands of commercial extracts were accurately
weighed (0.5 g) and extracted twice with 50 mL 70% MeOH
with ultrasonic shaking for 2 hr each time. The extracts were

After thawing, 300 µL decoction sample was mixed
with 700 µL methanol and the precipitate was removed by
centrifugation at 9860 x g for 15 min. The supernatant was
then further properly diluted with methanol. Two hundred µL
of the diluted sample was added with 200 µL of ethyl paraben
solution (20.0 µg/mL in methanol) and then filtered through
0.45 µm millipore membranes prior to HPLC analysis.
For the samples from commercial extract, proper dilution with methanol was carried out before the addition of
internal standard solution. The subsequent procedures were
identical to those for decoction samples.
VII. Validation of Assay Methods
The system suitability of this method was evaluated by
the intra-run and inter-run precision and accuracy of triplicates. The recoveries were further assessed by using the
external addition method.

RESULTS AND DISCUSSION
In this study, the water extract was prepared in a different manner from the standard decoction because only 2 g
sample was used. In order to extract the constituents more
thoroughly, forty times of water was used for extraction and
boiled until the volume was reduced to a quarter, which is
similar to the usual method of preparing a traditional decoction from 3 bowls to 80% of a bowl. As to the extractions of
commercial extracts by using 70% methanol, two times was
found almost exhaustive as had been previously determined.
An isocratic HPLC method was used for the simultaneous assay of three flavonoids – baicalin, baicalein, and wogonin of the decoction and commercial extract of Scutellariae
Radix. As shown in Figure 2, the three constituents baicalin,
baicalein, and wogonin as well as the internal standard (ethyl
paraben) were separated effectively within 35 min for both
traditional decoction and commercial extract. The retention
times of baicalin, baicalein and wogonin were 7.5, 15.6 and
33.9 min, respectively. In contrast to earlier reports on the
quantitative analysis of Scutellariae Radix(16,17), the present
method used a simple isocratic elution instead of a gradient
elution.
Good linear relationships were obtained for baicalin,
baicalein and wogonin over the concentration ranges of 3.1 –
100.0 µg/mL, (y = 0.0425x + 0.0012, r = 0.9999), 2.5 – 80.0
µg/mL, (y = 0.0623x – 0.0790, r = 0.9995) and 2.5 – 80.0
µg/mL, (y = 0.0655x + 0.0267, r = 0.9996), respectively. The
intra-run and inter-run precision and accuracy analysis of
baicalin, baicalein and wogonin indicated that CVs were
below 2.6%, 5.3%, 3.8% and relative errors were below
5.3%, 9.7%, 9.7%, respectively. The limits of quantitation
(LOQ) were 3.1 µ g/mL, 2.5 µ g/mL and 2.5 µ g/mL for
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Table 2. Contents (mg) of baicalin, baicalein and wogonin in each gram
commercial extracts of Scutellariae Radix
Samples
Baicalin
Baicalein
Wogonin
a1
123.3 ± 8.1
12.8 ± 0.5
4.8 ± 0.1
a2
116.8 ± 8.9
18.9 ± 0.2
6.7 ± 0.1
3
103.7 ± 3.3
13.7 ± 0.0
4.7 ± 0.0
4
93.7 ± 9.9
11.8 ± 0.4
4.7 ± 0.2
b5
78.8 ± 1.2
18.2 ± 0.3
6.2 ± 0.1
a6
74.7 ± 9.0
13.1 ± 0.6
5.5 ± 0.2
7
71.9 ± 4.9
29.2 ± 4.2
8.0 ± 1.2
8
67.5 ± 7.2
11.8 ± 0.2
5.0 ± 0.1
9
50.5 ± 1.1
15.0 ± 0.7
4.9 ± 0.2
10
41.8 ± 3.4
5.0 ± 0.1
2.2 0.0
5.3 ± 0.5
Mean ± S.E.
82.3 ± 8.5
15.0 2.0
Range
41.8~123.3
5.0~29.2
4.8~8.0
n = 3.
aherb powder added as labeled.
bherb powder observed.

1

2
42

3

3

Figure 2. Chromatograms of baicalin, baicalein and wogonin in the
water extract of Scutellariae Radix without internal standard (A) and
with internal standard (B); 1, baicalin; 2, baicalein; 3, wogonin; 4, internal standard (ethyl paraben).
Table 1. Contents (mg) of baicalin, baicalein and wogonin in water
extracts of each gram Scutellariae Radix
Samples
Baicalin
Baicalein
Wogonin
1
79.0 ± 3.1
5.6 ± 0.4
2.0 ± 0.1
2
77.5 ± 2.9
6.2 ± 0.3
2.3 ± 0.2
3
73.0 ± 1.6
6.4 ± 0.2
1.9 ± 0.1
4
70.7 ± 7.2
6.0 ± 0.5
1.6 ± 0.2
5
68.7 ± 3.2
4.8 ± 0.2
1.9 ± 0.1
6
63.0 ± 6.8
5.3 ± 0.1
1.8 ± 0.1
7
59.4 ± 2.9
5.5 ± 0.4
1.8 ± 0.2
8
54.4 ± 4.2
5.8 ± 0.1
1.4 ± 0.1
9
51.1 ± 3.1
5.4 ± 0.3
1.6 ± 0.1
10
30.7 ± 1.3
3.6 ± 0.3
0.9 ± 0.1
Mean ± S.E.
62.7 ± 4.6
5.5 ± 0.2
1.7 ± 0.1
Range
30.7~79.0
3.6~6.4
0.9~2.3
n=3.

baicalin, baicalein and wogonin, respectively. The limits of
detection (LOD) were 0.2 µg/mL, 0.3 µg/mL and 0.3 µg/mL
for baicalin, baicalein and wogonin, respectively. The recoveries from decoction determined in triplicates were 90.5 ±
0.3% at 12.5 µg/mL, 94.6 ± 2.7% at 25.0 µg/mL, 95.8 ± 1.5%
at 50.0 µg/mL for baicalin; 97.9 ± 2.2% at 10.0 µg/mL, 90.7
± 2.3% at 20.0 µ g/mL, 88.5 ± 1.2% at 40.0 µ g/mL for
baicalein; 110.7 ± 7.2% at 5.0 µg/mL, 99.2 ± 4.5% at 10.0
µg/mL, 96.1 ± 4.3% at 20.0 µg/mL for wogonin, respectively. The recoveries from commercial extracts were 97.8 ±
1.8% at 12.5 µg/mL, 89.2 ± 0.9% at 25.0 µg/mL and 104.3 ±

Table 3. Comparison of the contents (mg) of baicalin, baicalein and
wogonin in the maximum daily dose of traditional decoctions and commercial extracts of Scutellariae Radix
Water extracts of crude drug (9 g)
Samples
Baicalin
Baicalein
Wogonin
1
711.0 ± 22.7
50.2 ± 3.0
18.0 ± 0.9
2
697.5 ± 21.3
58.2 ± 1.9
20.5 ± 1.2
3
657.4 ± 14.7
57.4 ± 2.1
17.0 ± 0.8
4
636.7 ± 65.0
54.4 ± 4.3
14.8 ± 1.9
5
617.9 ± 28.9
43.4 ± 2.1
17.1 ± 0.8
6
567.0 ± 61.3
47.6 ± 1.0
16.5 ± 0.9
7
534.2 ± 21.1
49.5 ± 2.8
16.5 ± 1.3
8
489.9 ± 30.7
49.3 ± 0.4
12.9 ± 0.8
9
459.6 ± 22.6
49.0 ± 2.2
14.0 ± 0.9
10
276.1 ± 9.7
38.1 ± 2.5
8.4 ± 0.4
Mean ± S.E.
564.7 ± 41.7
49.7 ± 1.9
15.6 ± 1.0
Range
276.1~711.0
38.1~58.2
8.4~20.5
Commercial extracts
Samples
Baicalin
Baicalein
Wogonin
(max. daily dose)
a1 (1.2 g)
147.9 ± 9.7
15.4 ± 0.5
5.7 ± 0.4
a2 (3.6 g)
420.6 ± 32.1
67.9 ± 0.5
24.0 ± 0.6
3 (1.8 g)
186.7 ± 6.0
24.7 ± 0.1
8.5 ± 0.1
4 (2.25 g)
177.3 ± 2.6
41.0 ± 0.6
13.9 ± 0.4
b5 (5.4 g)
388.5 ± 26.5
157.8 ± 18.5
43.0 ± 5.2
a6 (9.0 g)
454.9 ± 9.7
135.4 ± 5.1
44.2 ± 1.0
7 (2.0 g)
187.4 ± 19.8
23.7 ± 0.8
9.4 ± 0.3
8 (3.6 g)
150.5 ± 12.3
17.9 ± 0.4
7.9 ± 0.1
9 (3.0 g)
224.2 ± 27.1
39.3 ± 1.8
16.6 ± 0.4
10 (1.2 g)
81.0 ± 8.7
14.1 ± 0.2
5.9 ± 0.1
Mean ± S.E.
241.9 ± 41.1
53.7 ± 16.4
17.9 ± 4.6
Range
81.0~454.9
14.1~157.8
5.7~44.2
aherb powder added as labeled.
bherb powder observed.

1.4% at 50.0 µg/mL for baicalin; 87.8 ± 4.2% at 10.0 µg/mL,
110.4 ± 1.8% at 20.0 µg/mL, and 98.2 ± 2.7% at 40.0 µg/mL
for baicalein; 103.6 ± 3.0% at 5.0 µg/mL, 99.8 ± 0.5% at 10.0
µg/mL and 97.2 ± 1.0% at 20.0 µg/mL for wogonin, respectively.
Our results indicated the contents of baicalin, baicalein
and wogonin in traditional decoctions of each gram
Scutellariae Radix were 62.7 ± 4.6 mg, 5.5 ± 0.2 mg and 1.7
± 0.1 mg, whereas those in each gram commercial extracts
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were 82.3 ± 8.5 mg, 15.0 ± 2.0 mg and 5.3 ± 0.5 mg, respectively, as shown in Table 1 and 2.
According to literature(18,19), the suggested daily dose of
the crude drug of Scutellariae Radix is in the range of 3.0-9.0
g, whereas that of commercial extract according to the labeling is in the range of 0.4-9.0 g. Therefore, based on our
results, the maximum daily doses of baicalin, baicalein and
wogonin administered from traditional decoction of
Scutellariae Radix are 564.7 ± 41.7 mg, 49.7 ± 1.9 mg and
15.6 ± 1.0 mg, whereas those from commercial extracts are
241.9 ± 41.1 mg, 53.7 ± 16.4 mg and 17.9 ± 4.6 mg, respectively, as shown in Table 3.
When the maximum daily doses of baicalin, baicalein
and wogonin are compared among the traditional decoctions
of ten crude drugs of Scutellariae Radix, the variations of the
three markers are about 2~3 fold, whereas among the ten
commercial extracts, the variation of baicalin is about 6 fold,
nevertheless, the variations of relatively nonpolar baicalein
and wogonin are about 8 ~ 11 fold, indicating larger variation
among different brands of commercial extracts than crude
drug decoctions.
When the doses of baicalin are compared between traditional decoctions and commercial extracts, the maximum
daily dose in commercial extract ranged 81.0~454.9 mg was
much lower than that of traditional decoction ranged 276.1~
711.0 mg. This suggests that the traditional decoction should
provide higher efficacy based on the intake of baicalin. As for
the maximum daily doses of baicalein and wogonin, three of
the ten commercial extracts were found even higher than all
the ten traditional decoctions. The labels of two among the
three extracts with higher baicalein and wogonin indicated
that herb powder was added as excipient and the third extract
showed the presence of herb powder under microscope
examination, although there was no declaration on the label.
The addition of herb powder could account for the higher
content of baicalein and wogonin in the commercial extracts.
In order to approach the requirements of GMP as western medicines, the quantitative control of herbal medicinal
products is very important. The simultaneous analysis of the
three flavonoids presented in this study is applicable for the
routine quality control of both the crude drug and commercial extract of Scutellariae Radix. It is suggested for manufacturers to label the contents of active constituents on their
herbal products to ensure the quality, efficacy and safety for
clinical use.
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